Proinflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokines (IL-10, IL-13) in the pathogenesis of sepsis in newborns and infants

Archivum Immunologiae et Therapiae Experimentalis

Volumn 49, Issue 5, 2001, Pages 399-404

  Sikora, Janusz Piotr ^a   Chlebna Sokół, Danuta ^a   Krzyzańska Oberbek, Alicja ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NONE

Author keywords

Children; Cytokine inhibitors; Cytokines; Sepsis

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; C REACTIVE PROTEIN; CALCITONIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; LEUKOCYTE ANTIGEN; PROCALCITONIN; PROTEIN PRECURSOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; METABOLISM; NEWBORN; PROGNOSIS; SEPSIS;

ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD; C-REACTIVE PROTEIN; CALCITONIN; CYTOKINES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-6; INTERLEUKIN-8; MALE; PROGNOSIS; PROTEIN PRECURSORS; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEPSIS;

EID: 0035753742     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. ATICI A., SATAR M., CETINER S. and YAMAN A. (1997): Serum tumor necrosis factor-alpha in neonatal sepsis. Am. J. Perinatol., 14, 401-404.
2. CHAKRABORTY A., BLUM R. A., CUTLER D. R. and JUSKO W. J. (1999): Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers. Clin. Pharmacol. Ther., 65, 304-318.
3. CHERNOFF A. E., GRANOWITZ E. V., SHAPIRO L., VANNIER E., LONNEMANN G., ANGEL J. B., KENNEDY J. S., RABSON A. R., WOLFF S. M. and DINARELLO C. A. (1995): A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol., 154, 5492-5499.
4. DE BONT E. S., MARTENS A., VAN RAAN J., SAMSON G., FETTER W. P., OKKEN A., DE LEIJ L. H. and KIPMEN J. L. (1994): Diagnostic value of plasma levels of tumor necrosis factor a (TNF-α) and interleukin-6 (IL-6) in newborns with sepsis. Acta Paediatr., 83, 696-699.
5. DERKX B., MARCHANT A., GOLDMAN M., BIJLMER R. and DEVENTER S. (1995): High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J. Infect. Dis., 171, 229-232.
6. DOUGHTY L., CARCILLLO J. A., KAPLAN S. and JANOSKY J. (1998): The compensatory anti-inflammatory cytokine interleukin-10 response in pediatric sepsis-induced multiple organ failure. Chest, 113, 1625-1631.
7. GOGOS C. A, DROSOU E., BASSARIS H. P. and SKOUTELIS A. (2000): Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J. Infect. Dis., 181, 176-180.
8. HATHERILL M., TIBBY S. M., TURNER C., RATNAVEL N. and MURDOCH I. A. (2000): Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit. Care Med., 28, 2591-2594.
9. KRAGSBJERG P., HOLMBERG H. and VIKERFORS T. (1996): Dynamics of blood cytokine concentrations in patients with bacteremic infections. Scand. J. Infect. Dis., 28, 391-398.
10. KUMAR A. and CREERY W. D. (2000): The therapeutic potential of interleukin 10 in infection and inflammation. Arch. Immunol. Ther. Exp., 48, 529-538.
11. KÜSTER H., WEISS M., WILLEITNER A., DETLEFSEN S., JEREMIAS I., ZBOJAN J., GEIGER R., LIPOWSKY G. and SIMBRUNER G. (1998): Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet, 352, 1271-1277.
12. LIEN E., LIABAKK N. B., JOHNSEN A. C., NONSTAD U., SUNDAN A. and ESPEVIK T. (1995): Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells. Eur. J. Immunol., 25, 2714-2717.
13. LOFTIS L. L., MEALS E. A. and ENGLISH B. K. (1997): Differential effects of pentoxifylline and interleukin-10 on production of tumor necrosis factor and inducible nitric oxide synthase by murine macrophages. J. Infect. Dis., 175, 1008-1011.
14. MARISCALCO M. M. (1998): Infection and the host response. In FUHRMAN B. P.: Pediatric critical care. Mosby, St. Louis, 979-994.
15. NICOLETTI F., MANCUSO G., CUSUMANO V., DI MARCO R., ZACCONE P., BENDTZEN K. and TETI G. (1997): Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. Eur. J. Immunol., 27, 1580-1583.
16. PARIS M. M., FRIEDLAND I. R., EHRETT S., HICKEY S. M., OLSEN K. D., HAUSEN E., THONAR M. A. and MCCRACKEN G. H. JR. (1995): Effect of interleukin-1 receptor antagonist and soluble tumor necrosis factor in animal models of infection. J. Infect. Dis., 171, 161-169.
17. TILG H., TREHU E., ATKINS M. B., DINARELLO C. A. and MIER J. W. (1994): Interleukin-6 as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood, 83, 113-118.
18. TORPY D. J., BORNSTEIN S. R. and CHROUSOS G. P. (1998): Leptin and interleukin-6 in sepsis. Horm. Metab. Res., 30, 726-729.
19. VAN DER POLL T., DE WAAL MALEFYT R., COYLE S. M. and LOWRY S. F. (1997): Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J. Infect. Dis., 175, 118-122.
20. VAN DISSEL J., VAN LANGEVELDE P., WESTENDORP R. G. J., KWAPPENBERG K. and FROLICH M. (1998): Antiinflammatory cytokine profile and mortality in febrile patients. Lancet, 351, 950-953.
21. VLESSIS A. A., GOLDMAN R. K. and TRUNKEY D. D. (1995): New concepts in the pathophysiology of oxygen metabolism during sepsis. Br. J. Surg., 82, 870-876.
22. ZIMMERMAN J. J. (1998): Sepsis/septic shock. In FUHRMAN B. P.: Pediatric critical care. Mosby, St. Louis, 1088-1100.